High dose chemotherapy followed by autologous hematopoietic rescue in Hodgkin's disease: long-term follow-up in 128 patients.

@article{Bierman1993HighDC,
  title={High dose chemotherapy followed by autologous hematopoietic rescue in Hodgkin's disease: long-term follow-up in 128 patients.},
  author={Philip Jay Bierman and R G Bagin and Sundar Jagannath and Julie Marie Vose and Gary Spitzer and Anne M Kessinger and Karel A. Dicke and James Olen Armitage},
  journal={Annals of oncology : official journal of the European Society for Medical Oncology},
  year={1993},
  volume={4 9},
  pages={767-73}
}
BACKGROUND There is little long-term follow-up information after autologous transplantation for Hodgkin's disease. We evaluated the influence of various prognostic factors and examined the outcome in 128 such patients. PATIENTS AND METHODS Patients received high dose cyclophosphamide, carmustine, and etoposide followed by autologous hematopoietic rescue. RESULTS Patients have been observed between 50-130 months (median 77 months) following transplantation. Overall survival at four years is… CONTINUE READING